European equities traded in the US as American depositary receipts were lower late Friday morning, declining 0.29% to 1,721.83 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biotech firm Evaxion (EVAX) and biopharmaceutical company Cellectis (CLLS), which rose 8.3% and 7.8% respectively. They were followed by telecommunications Nokia (NOK) and medical device maker EDAP (EDAP), which increased 3.6% and 2.9% respectively.

The decliners from continental Europe were led by 3D printer company Materialise (MTLS) and accommodations booking site trivago (TRVG), which fell 2.2% and 2% respectively. They were followed by lender ING (ING) biopharmaceutical company Grifols (GRFS), which were down 1.8% and 1.7% respectively.

The gainers from the UK and Ireland were led by biopharmaceutical company Mereo BioPharma Group (MREO) and cruise line operator Carnival (CUK), which advanced 3.2% and 1.1% respectively. They were followed by telecommunications operator Vodafone (VOD) and alcoholic beverage company Diageo (DEO), which were up 0.9% and 0.8% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical companies Akari Therapeutics (AKTX) and Biodexa Pharmaceuticals (BDRX), which dropped 6.4% and 4.3% respectively. They were followed by biopharmaceutical company Bicycle Therapeutics (BCYC) and mining company BHP Group (BHP), which lost 2.8% and 2.2% respectively.